Eczema epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Tag: Undo |
No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 7: | Line 7: | ||
==Eczema Epidemiology and Demographics== | ==Eczema Epidemiology and Demographics== | ||
*A recent study showed that persistence of [[disease]] 8 years from the [[onset]] is noted in 20% of [[children]].<ref name=" | *A recent study showed that persistence of [[disease]] 8 years from the [[onset]] is noted in 20% of [[children]].<ref name="pmid27544489">{{cite journal| author=Kim JP, Chao LX, Simpson EL, Silverberg JI| title=Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. | journal=J Am Acad Dermatol | year= 2016 | volume= 75 | issue= 4 | pages= 681-687.e11 | pmid=27544489 | doi=10.1016/j.jaad.2016.05.028 | pmc=5216177 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27544489 }} </ref> | ||
* [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413 }} </ref> | * [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413 }} </ref> | ||
*In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name=" | *In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name="pmid20739951">{{cite journal| author=Shaw TE, Currie GP, Koudelka CW, Simpson EL| title=Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. | journal=J Invest Dermatol | year= 2011 | volume= 131 | issue= 1 | pages= 67-73 | pmid=20739951 | doi=10.1038/jid.2010.251 | pmc=3130508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739951 }} </ref> <ref name="pmid25078665">{{cite journal| author=Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC| title=Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. | journal=J Invest Dermatol | year= 2015 | volume= 135 | issue= 1 | pages= 56-66 | pmid=25078665 | doi=10.1038/jid.2014.325 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25078665 }} </ref> | ||
* [[Prevalence]] of [[eczema]] has plateaued in high-income countries, with low- and middle-income countries still having increasing cases. <ref name="pmid29421277">{{cite journal| author=Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS | display-authors=etal| title=Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration. | journal=J Allergy Clin Immunol | year= 2018 | volume= 141 | issue= 5 | pages= 1668-1676.e16 | pmid=29421277 | doi=10.1016/j.jaci.2018.01.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29421277 }} </ref> | |||
==References== | ==References== | ||
| Line 15: | Line 16: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[ | [[category:Up to Date]] | ||
Latest revision as of 18:20, 14 July 2022
|
Eczema Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Eczema On the Web |
|
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. [1] [2] Eczema has more predilection in males. [3]
Eczema Epidemiology and Demographics
- A recent study showed that persistence of disease 8 years from the onset is noted in 20% of children.[4]
- Eczema has more predilection in males. [3]
- In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. [1] [2]
- Prevalence of eczema has plateaued in high-income countries, with low- and middle-income countries still having increasing cases. [5]
References
- ↑ 1.0 1.1 Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011). "Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health". J Invest Dermatol. 131 (1): 67–73. doi:10.1038/jid.2010.251. PMC 3130508. PMID 20739951.
- ↑ 2.0 2.1 Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC (2015). "Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study". J Invest Dermatol. 135 (1): 56–66. doi:10.1038/jid.2014.325. PMID 25078665.
- ↑ 3.0 3.1 Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
- ↑ Kim JP, Chao LX, Simpson EL, Silverberg JI (2016). "Persistence of atopic dermatitis (AD): A systematic review and meta-analysis". J Am Acad Dermatol. 75 (4): 681–687.e11. doi:10.1016/j.jaad.2016.05.028. PMC 5216177. PMID 27544489.
- ↑ Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS; et al. (2018). "Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration". J Allergy Clin Immunol. 141 (5): 1668–1676.e16. doi:10.1016/j.jaci.2018.01.019. PMID 29421277.